B Cell Subsets and Immune Checkpoint Expression in Patients with Chronic Lymphocytic Leukemia

Aviwe Ntsethe1, Zekhethelo Alondwe Mkhwanazi1, Phiwayinkosi Vusi Dludla2,3

  • 1School of Laboratory Medicine and Medical Sciences (SLMMS), University of KwaZulu-Natal, Durban 4000, South Africa.

Insights

In chronic lymphocytic leukemia (CLL), immune checkpoints programmed death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) are elevated on B cells. However, these checkpoint levels did not correlate with beta-2 microglobulin (B2M) in CLL patients.

Area of Science:

  • Immunology
  • Hematology
  • Oncology

Background:

  • Chronic lymphocytic leukemia (CLL) involves B cell dysfunction.
  • Immune checkpoints like PD-1 and CTLA-4 are upregulated in CLL and may relate to prognostic markers such as B2M.

Purpose of the Study:

  • To investigate immune checkpoint expression on B cell subsets in CLL patients.
  • To determine the correlation between immune checkpoint levels and B2M in CLL.

Main Methods:

  • Multi-color flow cytometry was used to analyze B cell subsets and immune checkpoint expression.
  • Enzyme-linked immunosorbent assay (ELISA) measured basal B2M levels.
  • 21 CLL patients and 12 healthy controls were included.

Main Results:

  • CLL patients exhibited higher levels of activated B cells compared to controls (p < 0.001).
  • Increased expression of PD-1 and CTLA-4 was observed on activated and memory B cells in CLL patients (p < 0.05).
  • No significant association was found between B2M levels and immune checkpoint expression on B cell subsets after adjusting for age and sex.

Conclusions:

  • CLL patients show elevated PD-1 and CTLA-4 on activated and memory B cells.
  • B2M levels are not correlated with these immune checkpoint expressions on B cells in the studied CLL cohort.

Related Concept Videos

B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
721
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K